We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current PDSB market cap is 89.28M. The company's latest EPS is USD -1.3804 and P/E is -2.07.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.82M | -9.42M | -12.7M | -10.52M | -10.41M |
| Net Income | -19.14M | -9.66M | -11.54M | -10.85M | -10.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.04M | -14.9M | -21.44M | -41.67M | -43.05M |
| Net Income | -7M | -14.85M | -16.92M | -40.86M | -42.94M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 77.01M | 68.45M | 63.75M | 57.19M | 59.39M |
| Total Liabilities | 33.01M | 27.44M | 31.31M | 32.7M | 33.26M |
| Total Equity | 44M | 41.01M | 32.44M | 24.48M | 26.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.49M | 30.89M | 67.2M | 77.01M | 59.39M |
| Total Liabilities | 2.79M | 3.76M | 3.99M | 33.01M | 33.26M |
| Total Equity | 11.7M | 27.13M | 63.21M | 44M | 26.13M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.71M | -13.19M | -18M | -25.18M | -33.64M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 34.29M | 4.57M | 4.81M | 5.61M | 16.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.07M | -13.15M | -12.49M | -25.71M | -33.64M |
| Investing | 29.38M | N/A | N/A | N/A | N/A |
| Financing | 750k | 29.83M | 48.89M | 34.29M | 16.38M |
| Market Cap | 89.28M |
| Price to Earnings Ratio | -2.07 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.57 |
| Price to Book Ratio | 3.4 |
| Dividend Yield | - |
| Shares Outstanding | 31.11M |
| Average Volume (1 week) | 381.49k |
| Average Volume (1 Month) | 646.65k |
| 52 Week Change | -69.44% |
| 52 Week High | 9.5445 |
| 52 Week Low | 2.59 |
| Spread (Intraday) | 0.02 (0.69%) |
| Company Name | PDS Biotechnology Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.pdsbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
